Influence of non‐surgical periodontal therapy on inflammasome biomarkers in periodontitis with and without diabetes mellitus

BACKGROUND: Periodontitis and type 2 diabetes mellitus (T2DM) are chronic inflammatory conditions linked through common pathogenic processes. Interleukin-18 (IL-18), absent in melanoma 2 (AIM2), and interferon gamma-inducible protein 16 (IFI16) have been associated with inflammatory pathways of both diseases. Limited data exist regarding the effect of non-surgical periodontal therapy (NSPT) on these biomarkers. This study was designed to evaluate and compare the effect of NSPT on serum levels of AIM2, IFI16, and IL-18 in stage III periodontitis patients with and without T2DM. METHODS: Ninety participants were allocated into three groups: periodontally healthy controls (group I), stage III periodontitis (group II), stage III periodontitis with T2DM (group III). The plaque index (PI), gingival index (GI), papillary bleeding index (PBI), probing pocket depth (PPD), clinical attachment level (CAL), gingival recession (GR), periodontal inflamed surface area (PISA), periodontal epithelial surface area (PESA), random blood sugar (RBS), HbA1c, AIM2, IFI16, and IL-18 were assessed at baseline in group I and also at 6 weeks in groups II and III. RESULTS: Serum AIM2, IFI16, and IL-18 levels were significantly elevated in periodontitis patients, with the highest concentrations observed in group III, followed by group II at baseline. NSPT significantly improved PPD, CAL, PISA, PESA, and glycemic status; serum biomarker levels were observed in both treatment groups with greater improvements observed in group III. CONCLUSION: Serum AIM2, IFI16, and IL-18 levels increased progressively from group I to group III and decreased significantly following NSPT, reflecting reduced periodontal and systemic inflammation. These biomarkers may serve as potential indicators linking periodontal inflammation with metabolic dysregulation in T2DM. TRIAL REGISTRATION: The trial was registered with the Clinical Trials Registry-India (CTRI/2024/06/068456). PLAIN LANGUAGE SUMMARY: Periodontitis and type 2 diabetes are closely linked because both are associated with inflammation. This study examined whether treating severe periodontitis without surgery could improve gum health and reduce inflammation in the body. Ninety participants, including healthy individuals and patients with periodontitis with or without diabetes, were evaluated before and after treatment. Patients with both periodontitis and diabetes had the highest levels of inflammation-related blood markers. Following treatment, periodontal health, blood sugar, and these blood markers improved, with the greatest benefits observed in patients with diabetes. These findings suggest that periodontal treatment may improve both oral and overall health. Non-surgical periodontal therapy improved periodontal health and reduced inflammatory blood biomarkers in patients with stage III periodontitis, with greater improvements in those with type 2 diabetes.

Authors

Institutions

Publication Details

Journal
Journal of Periodontology
Published
2026-11-17
DOI
https://doi.org/10.1002/jper.70233
Primary Topic
Oral microbiology and periodontitis research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Influence of non‐surgical periodontal therapy on inflammasome biomarkers in periodontitis with and without diabetes mellitus

Prachi Rathi, Madhur Mahesh Gupta, Dharmarajan Gopalakrishnan, Rajashri Abhay Kolte et al.
Journal of Periodontology
Oral microbiology and periodontitis research
article

Influence of non‐surgical periodontal therapy on inflammasome biomarkers in periodontitis with and without diabetes mellitus

Prachi Rathi, Madhur Mahesh Gupta, Dharmarajan Gopalakrishnan, Rajashri Abhay Kolte, Abhay Pandurang Kolte, Vidya Viswanathan, Radhika B Rathi
article en

Abstract

BACKGROUND: Periodontitis and type 2 diabetes mellitus (T2DM) are chronic inflammatory conditions linked through common pathogenic processes. Interleukin-18 (IL-18), absent in melanoma 2 (AIM2), and interferon gamma-inducible protein 16 (IFI16) have been associated with inflammatory pathways of both diseases. Limited data exist regarding the effect of non-surgical periodontal therapy (NSPT) on these biomarkers. This study was designed to evaluate and compare the effect of NSPT on serum levels of AIM2, IFI16, and IL-18 in stage III periodontitis patients with and without T2DM. METHODS: Ninety participants were allocated into three groups: periodontally healthy controls (group I), stage III periodontitis (group II), stage III periodontitis with T2DM (group III). The plaque index (PI), gingival index (GI), papillary bleeding index (PBI), probing pocket depth (PPD), clinical attachment level (CAL), gingival recession (GR), periodontal inflamed surface area (PISA), periodontal epithelial surface area (PESA), random blood sugar (RBS), HbA1c, AIM2, IFI16, and IL-18 were assessed at baseline in group I and also at 6 weeks in groups II and III. RESULTS: Serum AIM2, IFI16, and IL-18 levels were significantly elevated in periodontitis patients, with the highest concentrations observed in group III, followed by group II at baseline. NSPT significantly improved PPD, CAL, PISA, PESA, and glycemic status; serum biomarker levels were observed in both treatment groups with greater improvements observed in group III. CONCLUSION: Serum AIM2, IFI16, and IL-18 levels increased progressively from group I to group III and decreased significantly following NSPT, reflecting reduced periodontal and systemic inflammation. These biomarkers may serve as potential indicators linking periodontal inflammation with metabolic dysregulation in T2DM. TRIAL REGISTRATION: The trial was registered with the Clinical Trials Registry-India (CTRI/2024/06/068456). PLAIN LANGUAGE SUMMARY: Periodontitis and type 2 diabetes are closely linked because both are associated with inflammation. This study examined whether treating severe periodontitis without surgery could improve gum health and reduce inflammation in the body. Ninety participants, including healthy individuals and patients with periodontitis with or without diabetes, were evaluated before and after treatment. Patients with both periodontitis and diabetes had the highest levels of inflammation-related blood markers. Following treatment, periodontal health, blood sugar, and these blood markers improved, with the greatest benefits observed in patients with diabetes. These findings suggest that periodontal treatment may improve both oral and overall health. Non-surgical periodontal therapy improved periodontal health and reduced inflammatory blood biomarkers in patients with stage III periodontitis, with greater improvements in those with type 2 diabetes.

Journal of Periodontology
Maharashtra University of Health Sciences (IN), Manipal Academy of Higher Education (IN), NKP Salve Institute of Medical Sciences and Lata Mangeshkar Hospital (IN), Kasturba Medical College, Manipal (IN)
Oral microbiology and periodontitis research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon